Status:
COMPLETED
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Insomnia
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.
Detailed Description
The duration of treatment is 1 year.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of Insomnia
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00095043
Start Date
October 1 2004
Last Update
November 17 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.